• LifeVantage Corp LFVN.OQ reported quarterly adjusted earnings of 18 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 15 cents. The mean expectation of two analysts for the quarter was for earnings of 19 cents per share. Wall Street expected results to range from 17 cents to 20 cents per share.

• Revenue rose 0.7% to $47.56 million from a year ago; analysts expected $54.75 million.

• LifeVantage Corp's reported EPS for the quarter was 17 cents​.

• The company reported quarterly net income of $2.16 million.

• LifeVantage Corp shares had fallen by 24.6% this quarter and lost 58.1% so far this year.

FORECAST CHANGES

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for LifeVantage Corp is $24.00, about 70.8% above its last closing price of $7.00

This summary was machine generated from LSEG data November 4 at 11:33 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)